NCT07532161

Brief Summary

A gummy smile can negatively affect a patient's self-confidence and satisfaction with their appearance, leading many individuals to seek effective esthetic solutions. The etiology of this condition varies and may include vertical maxillary excess, short upper lip, hyperactive upper lip, gingival enlargement, or altered passive eruption. Lip Repositioning Surgery is one of the minimally invasive esthetic surgical procedures used to reduce the amount of gingival display during smiling. Despite its effectiveness, this surgery may be associated with challenges such as pain, swelling, delayed wound healing, and the possibility of postoperative relapse over time, which could compromise both esthetic and functional outcomes. To overcome these challenges and enhance surgical outcomes, adjunctive techniques have been introduced to promote healing and determine whether enhancing the biological healing process can reduce the rate of relapse after LRS. Among the most prominent of these are Injectable Platelet-Rich Fibrin (i-PRF) and Low-Level Laser Therapy (LLLT).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Apr 2026Jan 2027

First Submitted

Initial submission to the registry

April 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 15, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

April 9, 2026

Last Update Submit

April 24, 2026

Conditions

Keywords

Excessive gingival displayGummy smileLip Repositioning SurgeryInjectable Platelet-Rich Fibrin (i-PRF)Liquid Platelet-Rich FibrinLow-Level Laser Therapy (LLLT)Wound healingPostoperative relapseGingival display reductionEsthetic dentistry

Outcome Measures

Primary Outcomes (2)

  • Gingival display (mm)

    Measured in millimeters from the lowest point of the upper lip vermilion border to the free gingival margin of the maxillary teeth (from right second premolar to left second premolar) during full smile.

    Baseline and 1, 3 and 6 months postoperatively

  • Wound Healing Index

    Wound healing will be assessed using the Wound Healing Index (Huang, Neiva, and Wang, 2005). This is a categorical scale with scores ranging from 1 to 3: 1. = poor healing (significant gingival swelling or redness, severe patient discomfort, slough formation with suppuration); 2. = good healing (mild gingival swelling or redness, mild patient discomfort, slough formation without suppuration); 3. = complete healing (no gingival swelling, redness, suppuration, or patient discomfort, and no slough formation). Higher scores indicate better healing outcomes.

    weekly for 4 weeks postoperatively

Secondary Outcomes (7)

  • Postoperative Pain (VAS 0-100)

    Days 1-7 postoperatively

  • Postoperative Edema/Swelling

    Day 3 postoperatively

  • Esthetic Satisfaction (VAS 0-100)

    6 months postoperatively

  • Upper Lip External Length

    Baseline, 1,3 and 6 months postoperatively

  • Upper Lip Internal Length

    Baseline, 1, 3 and 6 months postoperatively

  • +2 more secondary outcomes

Study Arms (2)

Liquid Platelet-Rich Fibrin group

EXPERIMENTAL

This group will consist of 11 patients presenting with excessive gingival display due to upper lip hypermobility. Each patient will undergo lip repositioning surgery, followed by immediate injection of Liquid Platelet-Rich Fibrin after completion of the surgical procedure.

Other: Liquid Platelet-Rich Fibrin group

Low-Level Laser group

EXPERIMENTAL

This group will consist of 11 patients presenting with excessive gingival display due to upper lip hypermobility. Each patient will undergo lip repositioning surgery, followed by immediate application of low-level laser therapy (LLLT) after completion of the surgical procedure and at 3,7,10, and 14 days after surgery.

Other: low-level laser group

Interventions

A partial thickness elliptical mucogingival incision was made from the mesial of the central incisor to the mesial of the first molar bilaterally with preservation of the frenulum; vertical height set to twice the excessive gingival display (2:1 ratio), lower margin 1 mm coronal to the mucogingival junction. Epithelium elevated to expose connective tissue (preserving minor salivary glands). Periosteal sutures (4-0 Vicryl, 2-3 per side) placed where connective tissue ≥0.5 mm ; incision edges approximated with simple interrupted 4-0 silk sutures. 20 mL blood collected into additive-free plastic tubes and centrifuged at 300 × g for 5 minutes. The Liquid Platelet-Rich Fibrin layer was aspirated and injected immediately after surgery along incision margins and surrounding tissue at 1 mm depth, multiple points 2-3 mm apart (≈0.1 mL per injection) to achieve homogeneous distribution.

Liquid Platelet-Rich Fibrin group

A partial thickness elliptical mucogingival incision was made from the mesial of the central incisor to the mesial of the first molar bilaterally with preservation of the frenulum; vertical height set to twice the excessive gingival display (2:1 ratio), lower margin 1 mm coronal to the mucogingival junction. Epithelium elevated to expose connective tissue (preserving minor salivary glands). Periosteal sutures (4-0 Vicryl, 2-3 per side) placed where connective tissue ≥0.5 mm to ; incision edges approximated with simple interrupted 4-0 silk sutures. low-level laser applied to the surgical site (635nm, 200 mW) as part of the post-surgical treatment and at 3,7,10, and 14 days after surgery.

Low-Level Laser group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients of both genders.
  • Patients presenting with a gummy smile in the maxillary anterior region (more than 3 mm) due to upper lip hypermobility.
  • Age 18-50 years.
  • Systemically healthy individuals, classified as ASA physical status I or II according to the American Society of Anesthesiologists (ASA) classification; that is, patients without systemic disease or with mild, well-controlled systemic conditions.
  • Patients with good oral hygiene, defined as an O'Leary Plaque Index ≤ 40%.
  • No previous lip repositioning surgery.

You may not qualify if:

  • Pregnancy and lactation.
  • Individuals with a previous history of receiving facial Botox or filler injections.
  • Systemic diseases or conditions that contraindicate the use of local anesthesia.
  • Any physical condition that impairs the ability to perform proper oral hygiene measures.
  • Patients who are smokers or alcohol consumers.
  • Inability or unwillingness to cooperate.
  • In adequate width of attached gingiva.
  • Vertical maxillary excess (moderate to severe) requiring orthognathic intervention.
  • Short upper lip
  • Gingival display primarily caused by altered passive eruption requiring crown lengthening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Damascus university , Syria.

Damascus, Rif-dimashq Governorate, Syria

RECRUITING

Related Publications (8)

  • Miron RJ, Gruber R, Farshidfar N, Sculean A, Zhang Y. Ten years of injectable platelet-rich fibrin. Periodontol 2000. 2024 Feb;94(1):92-113. doi: 10.1111/prd.12538. Epub 2023 Nov 30.

    PMID: 38037213BACKGROUND
  • Alammar A, Heshmeh O, Mounajjed R, Goodson M, Hamadah O. A comparison between modified and conventional surgical techniques for surgical lip repositioning in the management of the gummy smile. J Esthet Restor Dent. 2018 Nov;30(6):523-531. doi: 10.1111/jerd.12433. Epub 2018 Nov 9.

    PMID: 30412347BACKGROUND
  • Farshidfar N, Amiri MA, Estrin NE, Ahmad P, Sculean A, Zhang Y, Miron RJ. Platelet-rich plasma (PRP) versus injectable platelet-rich fibrin (i-PRF): A systematic review across all fields of medicine. Periodontol 2000. 2025 Mar 24. doi: 10.1111/prd.12626. Online ahead of print.

    PMID: 40125556BACKGROUND
  • Sun G, Tuner J. Low-level laser therapy in dentistry. Dent Clin North Am. 2004 Oct;48(4):1061-76, viii. doi: 10.1016/j.cden.2004.05.004.

    PMID: 15464564BACKGROUND
  • Tawfik OK, El-Nahass HE, Shipman P, Looney SW, Cutler CW, Brunner M. Lip repositioning for the treatment of excess gingival display: A systematic review. J Esthet Restor Dent. 2018 Mar;30(2):101-112. doi: 10.1111/jerd.12352. Epub 2017 Nov 27.

    PMID: 29193632BACKGROUND
  • AlJasser RN. A Modified Approach in Lip Repositioning Surgery for Excessive Gingival Display to Minimize Post-Surgical Relapse: A Randomized Controlled Clinical Trial. Diagnostics (Basel). 2023 Feb 14;13(4):716. doi: 10.3390/diagnostics13040716.

    PMID: 36832213BACKGROUND
  • Tjan AH, Miller GD, The JG. Some esthetic factors in a smile. J Prosthet Dent. 1984 Jan;51(1):24-8. doi: 10.1016/s0022-3913(84)80097-9.

    PMID: 6583388BACKGROUND
  • Robbins JW. Differential diagnosis and treatment of excess gingival display. Pract Periodontics Aesthet Dent. 1999 Mar;11(2):265-72; quiz 273.

    PMID: 10321231BACKGROUND

Study Officials

  • Tarek Qasem, DDS MSc PhD

    Faculty of Dentistry, Damascus university, Syria.

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Randomized comparative clinical trial with blinded outcome assessment. Outcome assessment was performed by an independent examiner who was blinded to the treatment allocation. Clinical photographs and clinical measurements were coded and evaluated without revealing the group assignment. Statistical analysis was performed using coded data to ensure blinding of the data analyst.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2026

First Posted

April 15, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

January 31, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations